Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 358-363

  Li, Mei ^a   Zhao, Dan ^a   Ma, Gui ^a   Zhang, Baotong ^a   Fu, Xiaoying ^b   Zhu, Zhengmao ^a   Fu, Liya ^a   Sun, Xiaodong ^b   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATBF1; Breast epithelium; Progesterone; Progesterone receptor (PR)

Indexed keywords

ALPHA6 INTEGRIN; HERMES ANTIGEN; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ATBF1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; RNA INTERFERENCE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; HORMONE ANTAGONISTS; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED C57BL; MIFEPRISTONE; PROGESTERONE; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84872394049     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.009     Document Type: Article

References (33)

1. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990, 9:1603-1614.
2. Lanari C., Lamb C.A., Fabris V.T., Helguero L.A., Soldati R., Bottino M.C., Giulianelli S., Cerliani J.P., Wargon V., Molinolo A. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr. Relat. Cancer 2009, 16:333-350.
3. Sartorius C.A., Harvell D.M., Shen T., Horwitz K.B. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res. 2005, 65:9779-9788.
4. Horwitz K.B., Dye W.W., Harrell J.C., Kabos P., Sartorius C.A. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc. Natl. Acad. Sci. USA 2008, 105:5774-5779.
5. Kabos P., Haughian J.M., Wang X., Dye W.W., Finlayson C., Elias A., Horwitz K.B., Sartorius C.A. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res. Treat. 2011, 128:45-55.
6. Schramek D., Leibbrandt A., Sigl V., Kenner L., Pospisilik J.A., Lee H.J., Hanada R., Joshi P.A., Aliprantis A., Glimcher L., Pasparakis M., Khokha R., Ormandy C.J., Widschwendter M., Schett G., Penninger J.M. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010, 468:98-102.
7. Morinaga T., Yasuda H., Hashimoto T., Higashio K., Tamaoki T. A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol. Cell. Biol. 1991, 11:6041-6049.
8. Jung C.G., Kim H.J., Kawaguchi M., Khanna K.K., Hida H., Asai K., Nishino H., Miura Y. Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation. Development 2005, 132:5137-5145.
9. Miura Y., Tam T., Ido A., Morinaga T., Miki T., Hashimoto T., Tamaoki T. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J. Biol. Chem. 1995, 270:26840-26848.
10. Ido A., Miura Y., Tamaoki T. Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cells. Dev. Biol. 1994, 163:184-187.
11. Kataoka H., Joh T., Miura Y., Tamaoki T., Senoo K., Ohara H., Nomura T., Tada T., Asai K., Kato T., Itoh M. AT motif binding factor 1-A (ATBF1-A) negatively regulates transcription of the aminopeptidase N gene in the crypt-villus axis of small intestine. Biochem. Biophys. Res. Commun. 2000, 267:91-95.
12. Qi Y., Ranish J.A., Zhu X., Krones A., Zhang J., Aebersold R., Rose D.W., Rosenfeld M.G., Carriere C. Atbf1 is required for the Pit1 gene early activation. Proc. Natl. Acad. Sci. USA 2008, 105:2481-2486.
13. M. Li, X. Fu, G. Ma, X. Sun, X. Dong, T. Nagy, C. Xing, J. Li, J.T. Dong, Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling. PLoS One, 2012, in press.
14. Dong X.Y., Sun X., Guo P., Li Q., Sasahara M., Ishii Y., Dong J.T. ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells. J. Biol. Chem. 2010, 285:32801-32809.
15. Dong X.Y., Fu X., Fan S., Guo P., Su D., Dong J.T. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP. Biochem. J. 2012, 444:581-590.
16. Dong X.Y., Guo P., Sun X., Li Q., Dong J.T. Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells. J. Biol. Chem. 2011, 286:13879-13890.
17. Schultz J.R., Petz L.N., Nardulli A.M. Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression. Mol. Cell. Endocrinol. 2003, 201:165-175.
18. Giulianelli S., Vaque J.P., Soldati R., Wargon V., Vanzulli S.I., Martins R., Zeitlin E., Molinolo A.A., Helguero L.A., Lamb C.A., Gutkind J.S., Lanari C. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer Res. 2012, 72:2416-2427.
19. Dong X.Y., Guo P., Boyd J., Sun X., Li Q., Zhou W., Dong J.T. Implication of snoRNA U50 in human breast cancer. J. Genet. Genomics 2009, 36:447-454.
20. Chen C., Zhou Y., Zhou Z., Sun X., Otto K.B., Uht R.M., Dong J.T. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene 2004, 330:133-142.
21. Zhang Z., Zhang B., Li W., Fu L., Zhu Z., Dong J.T. Epigenetic silencing of miR-203 upregulates SNAI2 and contributes to the invasiveness of malignant breast cancer cells. Genes Cancer 2012, 2:782-791.
22. Sun X., Zhou Y., Otto K.B., Wang M., Chen C., Zhou W., Subramanian K., Vertino P.M., Dong J.T. Infrequent mutation of ATBF1 in human breast cancer. J. Cancer Res. Clin. Oncol. 2007, 133:103-105.
23. Nelson C.C., Hendy S.C., Shukin R.J., Cheng H., Bruchovsky N., Koop B.F., Rennie P.S. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol. Endocrinol. 1999, 13:2090-2107.
24. Liu R., Zhou Z., Zhao D., Chen C. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. Mol. Endocrinol. 2011, 25:1137-1144.
25. Cittelly D.M., Finlay-Schultz J., Howe E.N., Spoelstra N.S., Axlund S.D., Hendricks P., Jacobsen B.M., Sartorius C.A., Richer J.K. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene 2012.
26. Brisken C., O'Malley B. Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2010, 2:a003178.
27. Hennighausen L., Robinson G.W. Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 2005, 6:715-725.
28. Brisken C., Kaur S., Chavarria T.E., Binart N., Sutherland R.L., Weinberg R.A., Kelly P.A., Ormandy C.J. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 1999, 210:96-106.
29. Oakes S.R., Rogers R.L., Naylor M.J., Ormandy C.J. Prolactin regulation of mammary gland development. J. Mammary Gland Biol. Neoplasia 2008, 13:13-28.
30. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. USA 2003, 100:9744-9749.
31. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P.A., Clarke C.L., Stingl J., Waterhouse P.D., Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2011, 465:803-807.
32. Graham J.D., Mote P.A., Salagame U., van Dijk J.H., Balleine R.L., Huschtscha L.I., Reddel R.R., Clarke C.L. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 2009, 150:3318-3326.
33. Yang C., Chen L., Li C., Lynch M.C., Brisken C., Schmidt E.V. Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol. Cell. Biol. 2010, 30:3111-3125.